心臟瓣膜设备市场（按瓣膜位置、产品类型、年龄层和最终用户划分）—2025-2032 年全球预测

预计到 2032 年心臟瓣膜装置市场将成长至 190.1 亿美元，复合年增长率为 10.19%。

全面了解影响心臟瓣膜设备市场的领先临床、监管和营运驱动因素以及相关人员策略

心臟瓣膜器械领域正处于临床需求加速成长和技术快速进步的十字路口。器械设计、影像和微创治疗技术的进步，与日益增长的临床医生专业知识和不断发展的治疗途径相结合，重塑了心臟瓣膜疾病的治疗流程。随着患者群体老化和诊断检测的改进，器械製造商、医疗系统和专科诊所的相关人员面临着将技术创新转化为可衡量临床效益的机会和责任。

因此，该领域的策略规划需要综合观点监管复杂性、报销差异以及经导管和外科瓣膜治疗的运作现实。本引言重点阐述了临床证据发展、应用驱动因素和供应链韧性之间的相互关係，构成了执行摘要的架构。这些维度分析基础使决策者能够在动态竞争格局中，优先考虑那些能为患者带来持久价值的措施。

技术进步、成熟证据和策略伙伴关係的整合如何重塑临床应用、供应链和竞争动态

近年来，我们见证的不仅是产品的渐进式改进，更是变革性的转变，这些转变正在重塑医疗服务模式和商业动态。器械小型化、新一代组织治疗以及增强型影像引导植入技术共同降低了手术风险，并扩大了微创干预的候选范围。同时，证据生成也日趋成熟，随机试验和真实世界註册研究越来越多地为指南更新和付款人政策提供信息，从而加速了特定患者群体对新疗法的采用。

此外，技术开发商、影像专家和服务供应商之间的产业整合和策略联盟正在集中力量，创造新的规模效益。同时，供应链敏捷性和零件采购正成为策略重点，迫使製造商重新评估製造地和供应商多元化。总而言之，这些转变迫使企业重新思考产品系列、打入市场策略和上市后监测框架，以保持竞争优势并确保以患者为中心的治疗结果。

评估 2025 年美国关税政策对整个心臟瓣膜设备供应链的成本结构、筹资策略和采购惯例的连锁影响

美国将在2025年之前征收关税，这对包括心臟瓣膜技术在内的各类医疗设备的供应链经济性和筹资策略产生了显着影响。依赖跨境零件供应和成品运输的製造商面临着不断上升的投入成本和利润压力，这促使他们进行短期价格调整，并重新专注于服务成本分析。为此，采购主管加快了筛选替代供应商的步伐，尽可能实现本地化生产，并重新谈判长期合同，以稳定供应和成本风险。

同时，临床相关人员和医院系统的库存计划和资本采购计划也受到了潜在影响。为了缓解影响，许多医疗机构延长了择期瓣膜手术的前置作业时间，在临床适用的情况下优先考虑国内采购，并加强与製造商的合作以确保优先分配。展望未来，关税环境增强了垂直整合、货源冗余和自动化投资的奖励，从而降低了单位生产成本，同时也强调了在商业合约中透明的监管合规性和贸易风险管理的重要性。

分段分析揭示了瓣膜位置、产品结构、患者年龄和医疗保健环境如何决定设备设计优先顺序、临床要求和商业化路径

细緻的细分视角揭示了瓣膜位置、产品架构、患者人口统计特征以及影响临床需求和商业化途径的护理环境之间的差异动态。根据瓣膜位置，市场涵盖主动脉瓣、二尖瓣、肺动脉瓣和三尖瓣，每种瓣膜都呈现独特的解剖挑战、器械设计要求和临床医生培训要求。例如，主动脉介入仍然是经导管介入治疗中最成熟的领域，而二尖瓣和三尖瓣治疗在重新定位和修復导向技术方面的投资正在增加。这些差异推动了对明确证据和器械迭代的需求。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

• 微创治疗效果推动经经导管二尖瓣瓣膜修復快速普及
• 整合人工智慧驱动的影像分析，用于术前规划和个人化瓣膜选择
• 具有抗钙化聚合物涂层的下一代组织瓣膜的开发
• 将经导管三尖瓣植入技术扩展到高风险病患群体
• 新兴的远端医疗瓣膜置换术术后远端监控解决方案
• 经经皮中瓣手术的增加减少了重复开胸心臟手术
• 专注于透过新型组织工程和支架设计提高瓣膜耐用性
• 监管部门的核准加速了可吸收支架心臟瓣膜平台的商业化

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 心臟瓣膜装置市场（依瓣膜位置）

• 主动脉
• 二尖瓣
• 肺
• 三尖瓣

9. 心臟瓣膜装置市场（依产品类型）

• 机器
  • 双叶
  • 斜盘
• 组织
  • 牛
  • 猪

第 10 章心臟瓣膜装置市场（依年龄层）

• 成人
• 孩子们

第 11 章。心臟瓣膜设备市场（按最终用户）

• 门诊手术中心
• 医院
  • 社区医院
  • 三级医院

12. 心臟瓣膜设备市场（按地区）

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十三章心臟瓣膜装置市场（依类别）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十四章心臟瓣膜设备市场（依国家）

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十五章 竞争格局

• 2024年市占率分析
• 2024年FPNV定位矩阵
• 竞争分析
  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • LivaNova PLC
  • CryoLife, Inc.
  • MicroPort Scientific Corporation
  • Meril Life Sciences Private Limited
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • JenaValve Technology, Inc.

The Heart Valve Devices Market is projected to grow by USD 19.01 billion at a CAGR of 10.19% by 2032.

A comprehensive orientation to the advanced clinical, regulatory, and operational drivers reshaping the heart valve devices market and stakeholder strategies

The heart valve devices sector stands at the intersection of accelerating clinical need and rapid technological progression. Advances in device design, imaging, and minimally invasive delivery techniques have converged with expanded clinician expertise and evolving care pathways, reshaping treatment algorithms for valvular heart disease. As patient populations age and diagnostic detection improves, stakeholders across device manufacturers, health systems, and specialty practices face both opportunity and responsibility to translate innovation into measurable clinical benefit.

Consequently, strategic planning in this sector requires an integrated perspective that considers regulatory complexity, reimbursement variability, and the operational realities of delivering transcatheter and surgical valve therapies. This introduction frames the executive summary by emphasizing the interplay between clinical evidence development, adoption drivers, and supply chain resilience. By grounding analysis in these dimensions, decision-makers can prioritize initiatives that deliver durable value to patients while navigating a dynamic competitive landscape.

How converging technological advances, evidence maturation, and strategic partnerships are reconfiguring clinical adoption, supply chains, and competitive dynamics in the sector

Recent years have produced transformative shifts that extend beyond incremental product improvements to reconfigure care delivery models and commercial dynamics. Device miniaturization, next-generation tissue treatments, and enhanced imaging-guided implantation techniques have collectively lowered procedural risk profiles and broadened candidacy for less invasive interventions. At the same time, evidence generation has matured, with randomized trials and real-world registries increasingly informing guideline updates and payer policies, thereby accelerating adoption in selected patient cohorts.

Moreover, industry consolidation and strategic partnerships between technology developers, imaging specialists, and service providers have concentrated capabilities while creating new scale efficiencies. Concurrently, supply chain agility and component sourcing have risen as strategic priorities, prompting manufacturers to reassess manufacturing footprints and vendor diversification. Taken together, these shifts require organizations to reassess product portfolios, market access strategies, and post-market surveillance frameworks to sustain competitive advantage and ensure patient-centered outcomes.

Assessing the cascading effects of United States tariff policy in 2025 on cost structures, sourcing strategies, and procurement practices across heart valve device supply chains

The introduction of tariffs in the United States during 2025 introduced notable implications for supply chain economics and sourcing strategies across medical device categories, including heart valve technologies. Manufacturers dependent on cross-border component supply and finished-goods movement encountered increased input costs and margin pressure, prompting near-term price adjustments and renewed focus on cost-to-serve analysis. In response, procurement leaders accelerated efforts to qualify alternate suppliers, regionalize production where feasible, and renegotiate long-term contracts to stabilize supply and cost exposure.

In parallel, clinical stakeholders and hospital systems experienced potential impacts on inventory planning and capital procurement timelines. To mitigate disruption, many institutions extended lead times for elective valve procedures, prioritized domestic sourcing when clinically appropriate, and intensified collaboration with manufacturers to secure prioritized allocations. Looking forward, the tariff environment heightened incentives for vertical integration, sourced redundancy, and investment in automation to reduce unit production costs, while also reinforcing the importance of transparent regulatory compliance and trade risk management across commercial contracts.

Segment-specific analysis revealing how valve position, product architecture, patient age, and care setting collectively dictate device design priorities, clinical requirements, and commercialization pathways

A nuanced segmentation lens reveals differential dynamics across valve position, product architecture, patient demographics, and care settings that shape clinical demand and commercialization pathways. Based on Valve Position, market is studied across Aortic, Mitral, Pulmonary, and Tricuspid, each presenting unique anatomical challenges, device design imperatives, and clinician training requirements. For example, aortic interventions remain the most established arena for transcatheter approaches, while mitral and tricuspid therapies increasingly attract investment in repositionable and repair-oriented technologies. These distinctions drive distinct evidence needs and device iterations.

Based on Product Type, market is studied across Mechanical and Tissue. The Mechanical is further studied across Bileaflet and Tilting Disc. The Tissue is further studied across Bovine Pericardial and Porcine, and material selection continues to influence durability profiles, anticoagulation strategies, and patient preference. Based on Age Group, market is studied across Adult and Pediatric, where pediatric applications demand bespoke sizing, growth-accommodating designs, and long-term follow-up strategies that differ from adult therapeutic pathways. Based on End User, market is studied across Ambulatory Surgical Centers and Hospitals. The Hospitals is further studied across Community Hospital and Tertiary Care Hospital, and care setting influences procedural volumes, staffing competencies, capital equipment availability, and post-procedural care protocols. Integrating these segmentation dimensions yields targeted insights for clinical development prioritization, reimbursement engagement, and go-to-market sequencing that respond to heterogenous stakeholder requirements.

Regional dynamics that determine clinical adoption, regulatory navigation, and commercialization strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Geographic dynamics continue to shape regulatory pathways, reimbursement landscapes, and deployment strategies for heart valve devices across principal global regions. In the Americas, advanced clinical adoption and high-volume interventional programs coexist with diverse payer models that demand robust value demonstrations and health-economic evidence. Many manufacturers view this region as a focal point for pivotal trials and early commercial launches, while also navigating regional differences in procurement practices and hospital purchasing structures.

Across Europe, Middle East & Africa, regulatory harmonization efforts and national reimbursement frameworks create a mosaic of access conditions, leading firms to tailor market access plans to country-specific timelines. Investment in local clinician training and registry participation has proven effective in accelerating adoption in certain European markets. In the Asia-Pacific region, demographic trends and rapidly expanding cardiovascular care capacity are driving strong interest in both transcatheter and surgical valve solutions; however, market entry strategies require careful alignment with local regulatory frameworks, cost-containment pressures, and partnership models that can support scale-up while ensuring clinical quality. Collectively, regional approaches must balance centralized R&D priorities with localized commercialization tactics to achieve sustainable market penetration.

Insights on how incumbent and emerging companies are differentiating through clinical evidence generation, platform innovation, manufacturing optimization, and value-based commercial models

Competitive positioning in the heart valve devices arena reflects a blend of legacy surgical expertise, emergent transcatheter capabilities, and differentiated platform strategies. Leading firms continue to invest in incremental device improvements such as delivery systems, leaflet materials, and anti-calcification processes, while challengers pursue disruptive innovations in repair technologies, polymeric leaflets, and imaging-integrated implantation systems. Partnerships with imaging and digital health companies augment device value propositions by improving procedural precision and enabling post-market outcome tracking.

Additionally, strategic focus areas for companies include expanding label indications through clinical programs, strengthening post-market evidence via registries, and optimizing manufacturing footprints to ensure quality and cost efficiency. Commercial models are evolving to reflect value-based contracting and outcome-linked reimbursement in select healthcare systems, necessitating stronger provider engagement and outcome measurement capabilities. Firms that combine robust clinical evidence, scalable manufacturing, and proactive market-access strategies are better positioned to convert technological advances into sustained clinical adoption and commercial performance.

Actionable strategic imperatives for executives to strengthen supply resilience, align evidence generation with payers, and invest in platform innovations to secure durable clinical and commercial advantage

Industry leaders should pursue a dual-track strategy that balances near-term operational resilience with medium-term innovation investment to capture evolving opportunities in valve therapy. In the near term, executives should prioritize supply chain diversification, including qualifying alternate component suppliers and exploring regional manufacturing options to reduce tariff and logistics exposure. Simultaneously, commercial teams should strengthen hospital partnerships and clinician education programs to preserve procedural volumes and ensure consistent device utilization across care settings.

Over the medium term, organizations must invest in clinically meaningful differentiation such as tissue treatments that extend durability, delivery systems that simplify implantation, and digital tools that support patient selection and follow-up. Companies should also align evidence plans with payer requirements early in product development to facilitate smoother market access. Finally, pursuing strategic collaborations-whether with imaging specialists, contract manufacturers, or regional distributors-will accelerate scale and reduce time to market, enabling firms to convert technical leadership into commercial advantage while maintaining focus on patient outcomes.

A rigorous mixed-methods research approach combining stakeholder interviews, clinical evidence review, regulatory analysis, and supply chain benchmarking to ensure actionable insights

The research synthesis underpinning this executive summary draws on a layered methodology that integrates primary stakeholder interviews, clinical literature review, regulatory documentation, and operational benchmarking. Primary qualitative interviews were conducted with clinicians, hospital procurement leaders, and device developers to surface real-world adoption drivers, procedural workflow considerations, and post-market surveillance practices. These insights were triangulated with peer-reviewed clinical trials, guideline committee statements, and regulatory approvals to ensure alignment between observed practice patterns and formal evidence thresholds.

To capture commercial and operational dynamics, the methodology incorporated supply chain mapping and vendor ecosystem analysis, examining manufacturing footprints, component sourcing dependencies, and distribution channels. Wherever possible, findings were validated through cross-referencing multiple independent sources and through iterative expert review to enhance reliability. This mixed-methods approach ensures that strategic recommendations rest on both empirical evidence and practical, on-the-ground knowledge of clinical and commercial realities.

A concise synthesis of how technological, clinical, and economic forces collectively define priorities for innovation, market access, and supply chain resilience in valve therapy

In summary, the heart valve devices landscape is undergoing a period of structural change driven by technological maturation, increasingly sophisticated evidence requirements, and shifting economic pressures. Devices are becoming less invasive, procedural precision is improving, and collaborative models are emerging that integrate imaging and digital tools to enhance outcomes. These trends create clear pathways for innovators, but they also raise the bar for manufacturability, regulatory preparedness, and post-market evidence collection.

As stakeholders navigate tariff-related cost pressures, varied regional access conditions, and the nuances of segment-specific demand, success will favor organizations that adopt an integrated strategy: resilient and adaptable supply chains, targeted clinical development that aligns with payer evidence needs, and commercial models that prioritize outcomes and provider partnerships. By focusing on these priorities, companies can convert scientific progress into reproducible clinical benefit and sustainable commercial performance across diverse care settings.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Surge in transcatheter mitral valve repair adoption driven by minimally invasive outcomes
• 5.2. Integration of AI-driven imaging analytics for preoperative planning and personalized valve selection
• 5.3. Development of next-generation bioprosthetic valves with anti-calcification polymer coatings
• 5.4. Expansion of transcatheter tricuspid valve implantation technologies for high-risk patient cohorts
• 5.5. Emergence of telemedicine-enabled remote monitoring solutions for postvalve replacement care
• 5.6. Growth in percutaneous valve-in-valve procedures reducing repeat open-heart surgeries
• 5.7. Focus on valve durability enhancements through novel tissue engineering and scaffold designs
• 5.8. Regulatory approvals accelerating commercialization of resorbable stented heart valve platforms

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Heart Valve Devices Market, by Valve Position

• 8.1. Aortic
• 8.2. Mitral
• 8.3. Pulmonary
• 8.4. Tricuspid

9. Heart Valve Devices Market, by Product Type

• 9.1. Mechanical
  • 9.1.1. Bileaflet
  • 9.1.2. Tilting Disc
• 9.2. Tissue
  • 9.2.1. Bovine Pericardial
  • 9.2.2. Porcine

10. Heart Valve Devices Market, by Age Group

• 10.1. Adult
• 10.2. Pediatric

11. Heart Valve Devices Market, by End User

• 11.1. Ambulatory Surgical Centers
• 11.2. Hospitals
  • 11.2.1. Community Hospital
  • 11.2.2. Tertiary Care Hospital

12. Heart Valve Devices Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Heart Valve Devices Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Heart Valve Devices Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Analysis
  • 15.3.1. Edwards Lifesciences Corporation
  • 15.3.2. Medtronic plc
  • 15.3.3. Abbott Laboratories
  • 15.3.4. Boston Scientific Corporation
  • 15.3.5. LivaNova PLC
  • 15.3.6. CryoLife, Inc.
  • 15.3.7. MicroPort Scientific Corporation
  • 15.3.8. Meril Life Sciences Private Limited
  • 15.3.9. Lepu Medical Technology (Beijing) Co., Ltd.
  • 15.3.10. JenaValve Technology, Inc.

LIST OF FIGURES

• FIGURE 1. GLOBAL HEART VALVE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 11. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. EUROPE HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. AFRICA HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASEAN HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GCC HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. BRICS HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. G7 HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. NATO HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. HEART VALVE DEVICES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 28. HEART VALVE DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. HEART VALVE DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL HEART VALVE DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL HEART VALVE DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AORTIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AORTIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AORTIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AORTIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AORTIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AORTIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MITRAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MITRAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MITRAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MITRAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MITRAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MITRAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PULMONARY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PULMONARY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PULMONARY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PULMONARY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PULMONARY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PULMONARY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TRICUSPID, BY REGION, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TRICUSPID, BY REGION, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TRICUSPID, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TRICUSPID, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TRICUSPID, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TRICUSPID, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY BILEAFLET, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY BILEAFLET, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY BILEAFLET, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY BILEAFLET, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY BILEAFLET, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY BILEAFLET, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TILTING DISC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TILTING DISC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TILTING DISC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TILTING DISC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TILTING DISC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TILTING DISC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TISSUE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TISSUE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TISSUE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY BOVINE PERICARDIAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY BOVINE PERICARDIAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY BOVINE PERICARDIAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY BOVINE PERICARDIAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY BOVINE PERICARDIAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY BOVINE PERICARDIAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PORCINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PORCINE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PORCINE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PORCINE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PORCINE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PORCINE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY COMMUNITY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY COMMUNITY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY COMMUNITY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY COMMUNITY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY COMMUNITY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY COMMUNITY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TERTIARY CARE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TERTIARY CARE HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TERTIARY CARE HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TERTIARY CARE HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TERTIARY CARE HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY TERTIARY CARE HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 118. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 119. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
• TABLE 120. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2025-2032 (USD MILLION)
• TABLE 121. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 122. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 123. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
• TABLE 124. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
• TABLE 125. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 126. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 127. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 128. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 129. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 130. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 131. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 132. AMERICAS HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 133. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 134. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 135. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
• TABLE 136. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2025-2032 (USD MILLION)
• TABLE 137. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 138. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 139. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
• TABLE 140. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
• TABLE 141. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 142. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 143. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 144. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 145. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 146. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 147. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 148. NORTH AMERICA HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 149. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 150. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 151. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
• TABLE 152. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2025-2032 (USD MILLION)
• TABLE 153. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 154. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 155. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
• TABLE 156. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
• TABLE 157. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 158. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 159. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 160. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 161. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 162. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 163. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 164. LATIN AMERICA HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 165. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 166. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 167. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
• TABLE 168. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2025-2032 (USD MILLION)
• TABLE 169. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 170. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 171. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 180. EUROPE, MIDDLE EAST & AFRICA HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 181. EUROPE HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 182. EUROPE HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 183. EUROPE HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
• TABLE 184. EUROPE HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2025-2032 (USD MILLION)
• TABLE 185. EUROPE HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 186. EUROPE HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 187. EUROPE HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
• TABLE 188. EUROPE HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
• TABLE 189. EUROPE HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 190. EUROPE HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 191. EUROPE HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 192. EUROPE HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 193. EUROPE HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 194. EUROPE HEART VALVE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 195. EUROPE HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 196. EUROPE HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 197. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 198. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 199. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
• TABLE 200. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2025-2032 (USD MILLION)
• TABLE 201. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 202. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 203. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
• TABLE 204. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
• TABLE 205. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 206. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 207. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 208. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 209. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 210. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 211. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 212. MIDDLE EAST HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 213. AFRICA HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 214. AFRICA HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 215. AFRICA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
• TABLE 216. AFRICA HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2025-2032 (USD MILLION)
• TABLE 217. AFRICA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 218. AFRICA HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 219. AFRICA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
• TABLE 220. AFRICA HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
• TABLE 221. AFRICA HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 222. AFRICA HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 223. AFRICA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 224. AFRICA HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 225. AFRICA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 226. AFRICA HEART VALVE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 227. AFRICA HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 228. AFRICA HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 229. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 230. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 231. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
• TABLE 232. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2025-2032 (USD MILLION)
• TABLE 233. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 234. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 235. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
• TABLE 236. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
• TABLE 237. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 238. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 239. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 240. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 241. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 242. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 243. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 244. ASIA-PACIFIC HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 245. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 246. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 247. ASEAN HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 248. ASEAN HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 249. ASEAN HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
• TABLE 250. ASEAN HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2025-2032 (USD MILLION)
• TABLE 251. ASEAN HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 252. ASEAN HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 253. ASEAN HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
• TABLE 254. ASEAN HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
• TABLE 255. ASEAN HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 256. ASEAN HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 257. ASEAN HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 258. ASEAN HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 259. ASEAN HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 260. ASEAN HEART VALVE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 261. ASEAN HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 262. ASEAN HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 263. GCC HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 264. GCC HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 265. GCC HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
• TABLE 266. GCC HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2025-2032 (USD MILLION)
• TABLE 267. GCC HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 268. GCC HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 269. GCC HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
• TABLE 270. GCC HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
• TABLE 271. GCC HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 272. GCC HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 273. GCC HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 274. GCC HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 275. GCC HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 276. GCC HEART VALVE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 277. GCC HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 278. GCC HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 279. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 280. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 281. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
• TABLE 282. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2025-2032 (USD MILLION)
• TABLE 283. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 284. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 285. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
• TABLE 286. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
• TABLE 287. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 288. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 289. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 290. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 291. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 292. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 293. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 294. EUROPEAN UNION HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 295. BRICS HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 296. BRICS HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 297. BRICS HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
• TABLE 298. BRICS HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2025-2032 (USD MILLION)
• TABLE 299. BRICS HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 300. BRICS HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 301. BRICS HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
• TABLE 302. BRICS HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
• TABLE 303. BRICS HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 304. BRICS HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 305. BRICS HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 306. BRICS HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 307. BRICS HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 308. BRICS HEART VALVE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 309. BRICS HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 310. BRICS HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 311. G7 HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 312. G7 HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 313. G7 HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
• TABLE 314. G7 HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2025-2032 (USD MILLION)
• TABLE 315. G7 HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 316. G7 HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 317. G7 HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
• TABLE 318. G7 HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
• TABLE 319. G7 HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 320. G7 HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 321. G7 HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 322. G7 HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 323. G7 HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 324. G7 HEART VALVE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 325. G7 HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 326. G7 HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 327. NATO HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 328. NATO HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 329. NATO HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
• TABLE 330. NATO HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2025-2032 (USD MILLION)
• TABLE 331. NATO HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 332. NATO HEART VALVE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 333. NATO HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2018-2024 (USD MILLION)
• TABLE 334. NATO HEART VALVE DEVICES MARKET SIZE, BY MECHANICAL, 2025-2032 (USD MILLION)
• TABLE 335. NATO HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
• TABLE 336. NATO HEART VALVE DEVICES MARKET SIZE, BY TISSUE, 2025-2032 (USD MILLION)
• TABLE 337. NATO HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 338. NATO HEART VALVE DEVICES MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 339. NATO HEART VALVE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 340. NATO HEART VALVE DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 341. NATO HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 342. NATO HEART VALVE DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 343. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 344. GLOBAL HEART VALVE DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 345. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2018-2024 (USD MILLION)
• TABLE 346. UNITED STATES HEART VALVE DEVICES MARKET SIZE, BY VALVE POSITION, 2025-2032 (USD MILLION)
• TABLE 347. UNITED STATES HEART VALVE D